Las Vegas Pain Institute and Medical Center, LLC
Las Vegas Pain Institute and Medical Center, LLC was paid $7.14M by Medicaid between Jan 2018 and Dec 2024, across 98 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoLAS VEGAS PAIN INSTITUTE AND MEDICAL CENTER, LLC
LAS VEGAS, NV 89103
LAS VEGAS, NV 89103
33aNPI1659431443assigned 12/11/2006
33bProvider typeChiropractor
28Total paid$7.14M
24GClaims289,101
24DCodes billed98
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Chiropractor providers in Nevada
Rank by total paid#1 of 9
Median peer was paid$32K
This provider vs. median226×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 53,687 | $1.39M | |
| 2019 | 49,620 | $1.09M | |
| 2020 | 40,124 | $937K | |
| 2021 | 36,210 | $913K | |
| 2022 | 35,081 | $933K | |
| 2023 | 38,050 | $1.01M | |
| 2024incomplete | 36,329 | $875K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 44,878 | 35,710 | $2.17M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 32,310 | 26,188 | $1.12M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 13% | 18,758 | 7,713 | $929K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.8% | 17,857 | 15,496 | $415K |
| 99152 | 4.3% | 13,145 | 7,586 | $306K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.2% | 10,793 | 8,001 | $299K |
| 64493 | 2.4% | 3,162 | 1,727 | $169K | |
| 64483 | 1.9% | 2,184 | 1,471 | $137K | |
| 64635 | 1.8% | 1,174 | 646 | $130K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 1,155 | 1,016 | $107K |
| 27096 | 1.4% | 2,720 | 1,651 | $101K | |
| 64494 | 1.3% | 3,091 | 1,693 | $93K |
86 more codes
| 20610 | 1.3% | 5,151 | $90K | |
| 64484 | 1.2% | 2,037 | $86K | |
| 01992 | <1% | 726 | $68K | |
| 64636 | <1% | 1,136 | $66K | |
| 64495 | <1% | 2,226 | $62K | |
| 64490 | <1% | 1,042 | $61K | |
| 97113 | <1% | 896 | $58K | |
| 97162 | <1% | 1,557 | $57K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,656 | $57K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 500 | $54K |
| 63650 | <1% | 231 | $42K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,377 | $36K |
| 36514 | <1% | 2,744 | $35K | |
| 64491 | <1% | 1,040 | $34K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 498 | $32K |
| 64492 | <1% | 956 | $31K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,859 | $31K |
| 64633 | <1% | 256 | $29K | |
| 64634 | <1% | 258 | $17K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 97 | $17K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 971 | $15K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 792 | $15K |
| 64479 | <1% | 177 | $14K | |
| 20552 | <1% | 472 | $13K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 11,422 | $12K |
| 64480 | <1% | 174 | $11K | |
| 73700 | <1% | 61 | $10K | |
| 72131 | <1% | 71 | $8K | |
| 62323 | <1% | 168 | $8K | |
| 20611 | <1% | 426 | $8K | |
| 72141 | <1% | 83 | $7K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 107 | $7K |
| 97161 | <1% | 180 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 55 | $7K |
| 95972 | <1% | 189 | $6K | |
| 99205 | Prolong outpt/office vis | <1% | 59 | $6K |
| 97164 | <1% | 172 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,065 | $4K |
| 77002 | <1% | 396 | $4K | |
| 72146 | <1% | 25 | $3K | |
| 64418 | <1% | 44 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 225 | $2K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 13,769 | $2K |
| 80050 | General health panel | <1% | 102 | $2K |
| 77003 | <1% | 173 | $2K | |
| 80305 | <1% | 350 | $2K | |
| 64450 | <1% | 48 | $1K | |
| 97124 | <1% | 78 | $1K | |
| 72100 | <1% | 58 | $1K | |
| J3490 | Unclassified drugs | <1% | 1,397 | $1K |
| 62321 | <1% | 36 | $1K | |
| 72128 | <1% | 16 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 84 | $1K |
| 84481 | <1% | 182 | $1K | |
| 93000 | <1% | 137 | $971.17 | |
| 80061 | Lipid panel | <1% | 166 | $795.18 |
| 72202 | <1% | 47 | $733.96 | |
| A4213 | Syringe, sterile, 20 cc or greater, each | <1% | 6,475 | $595.05 |
| 84439 | <1% | 181 | $584.25 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 154 | $556.08 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 66 | $502.20 |
| A4247 | Betadine or iodine swabs/wipes, per box | <1% | 1,896 | $451.17 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 11,291 | $428.04 |
| 73562 | <1% | 18 | $336.15 | |
| 81002 | <1% | 327 | $267.75 | |
| 87400 | <1% | 70 | $261.76 | |
| J1094 | Injection, dexamethasone acetate, 1 mg | <1% | 456 | $199.74 |
| 87430 | <1% | 36 | $171.78 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 3,158 | $162.74 |
| 84154 | <1% | 17 | $112.95 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 1,104 | $96.67 |
| 82948 | <1% | 76 | $91.68 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 22 | $90.57 |
| A6220 | Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing | <1% | 10,180 | $81.18 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 77 | $69.03 |
| 80053 | Comprehensive metabolic panel | <1% | 59 | $36.05 |
| A4215 | Needle, sterile, any size, each | <1% | 1,521 | $18.72 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $8.87 |
| A4210 | Needle-free injection device, each | <1% | 1,396 | $8.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 65 | $2.66 |
| A4930 | Gloves, sterile, per pair | 0% | 536 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 46 | $0.00 |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | 0% | 17,832 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 9,174 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 196 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 194 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMADUKA, GODWIN (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Spring Valley Surgery Center, LLC | Las Vegas, NV | $7.61M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.